Mircotechnologies/Biotech, ETHZ

Cell imaging patform to accelerate drug discovery.

MaxWell Biosystems AG provides
 a label-free cell-imaging
 platform to assess the clinical 
potential of brain drugs with
 high precision. Their micro-electrode array (MEA) technology
 can augment and complement 
high-content imaging systems
 by providing functional, electro-
physiological readouts. Their technology, which is based on micro-sensor fabricated in CMOS technology, enables readouts with high signal quality, high resolution, and high throughput.